Themis Medicare Limited (THEMISMED) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE083B01024
Key metrics
- Market Cap
- ₹1,166 Cr
- P/E Ratio
- 28.98
- EPS
- 4.33
- Book Value
- 43.28
- P/B Ratio
- 2.94
- ROE
- 0.29%
- ROCE
- -1.99%
- Debt / Equity
- 0.25
- Net Margin
- 0.33%
- Revenue Growth
- -15.6%
- Profit Growth
- -96.17%
- Dividend Yield
- 0.4%
- 52W High
- ₹148.00
- 52W Low
- ₹64.95
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 48.36%
The full Themis Medicare Limited analysis
Create a free account to open the complete THEMISMED deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.